Nisa Investment Advisors
TNGX icon

Nisa Investment Advisors’s Tango Therapeutics TNGX Stock Holding History

Nisa Investment Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$194K Sell
6,216
-1,024
-14% -$25.3K ﹤0.01% 1255
2026
Q1 		$151K Buy
7,240
+5,500
+316% +$76.6K ﹤0.01% 1301
2025
Q4 		$15.4K Hold
1,740
– – ﹤0.01% 2044
2025
Q3 		$14.6K Buy
1,740
+700
+67% +$4.74K ﹤0.01% 2127
2025
Q2 		$5.33K Sell
1,040
-2,590
-71% -$6.4K ﹤0.01% 2438
2025
Q1 		$4.97K Buy
+3,630
New +$8.91K ﹤0.01% 2254
2024
Q4 		– Sell
-98
Closed -$755 – 3055
2024
Q3 		$755 Sell
98
-9
-8% -$86 ﹤0.01% 2636
2024
Q2 		$918 Buy
107
+55
+106% +$425 ﹤0.01% 2536
2024
Q1 		$413 Buy
52
+27
+108% +$289 ﹤0.01% 2531
2023
Q4 		$248 Sell
25
-1,030
-98% -$8.94K ﹤0.01% 2523
2023
Q3 		$11.9K Buy
+1,055
New +$6.43K ﹤0.01% 2141
2023
Q1 		– Sell
-14,290
Closed -$104K – 2706
2022
Q4 		$104K Buy
14,290
+52
+0.4% +$366 ﹤0.01% 1546
2022
Q3 		$105K Buy
+14,238
New +$60.8K ﹤0.01% 1489

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Nisa Investment Advisors's TNGX Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Tango Therapeutics (TNGX) stake by 14% in Q2 2026, selling an estimated $25.3K and leaving 6,216 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #1255.

Nisa Investment Advisors first reported a position in TNGX in Q3 2022 and has held it in 13 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Nisa Investment Advisors held 6,216 shares of Tango Therapeutics worth $194K as of Q2 2026.
  • Nisa Investment Advisors sold 1,024 Tango Therapeutics shares in Q2 2026, an estimated $25.3K.
  • Tango Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1255 holding.
  • Nisa Investment Advisors first reported a position in Tango Therapeutics in Q3 2022 and has held it in 13 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.